MVIS® US Listed Pharmaceutical 25 Index
The MVIS® US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.
Country Weightings
Country weightings are based on the weightings of all index components in a certain country.
| Country | Components | Weight |
| Canada | 1 | 0.96% |
| United States | 14 | 52.06% |
| Denmark | 1 | 5.69% |
| France | 1 | 5.19% |
| Ireland | 2 | 3.74% |
| Netherlands | 1 | 3.67% |
| Switzerland | 1 | 5.19% |
| United Kingdom | 3 | 14.71% |
| Israel | 1 | 4.26% |
| Japan | 1 | 4.53% |
| Total | 26 | 100.00% |
| Sector | Components | Weight |
| Consumer Staples | 1 | 4.86% |
| Health Care | 24 | 95.14% |
| Unclassified | 1 | 0.00% |
| Total | 26 | 100.00% |
Size Weightings
- Large-Cap: companies with a market capitalisation above 6,000 mln
USD
- Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln
USD
- Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln
USD
- Micro-Cap: companies with a market capitalisation up to 200 mln
USD
| Size | Market Cap | Components | Weight |
| Large-Cap | 2,941,352,141,000 USD | 20 | 94.56% |
| Mid-Cap | 19,283,649,000 USD | 5 | 5.44% |
| Small-Cap | - | - | - |
| Micro-Cap | - | - | - |
| Total | 2,960,635,790,000 USD | 25 | 100.00% |
